Total Funding
59
3
Total FundingDebt Financing raised
Growth Score
-2 pts
Heat Score
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119548
Rokote Laboratories is a finnish vaccine development company.
- Tuija Keinonen: Chief Executive Officer
- Seppo Ylä-Herttuala: Co-Founder and Chairman of the Board
About the Company
Rokote Laboratories develops COVID-19 vaccine. In their vaccine, the cells of the nasopharynx are designed to create the SARS-CoV-2 virus's spike protein, which triggers an immune response. The second-generation coronavirus vaccine FINCoVac 2.1, which aims to offer strong protection against the coronavirus's quickly evolving variants, is
the current focus of product development at Rokote Laboratories. To establish the use of novel vaccine technology in Finland is the aim of the company's development work.
